Point of Care Technologies for Nutrition, Infection, and Cancer for Global Health (PORTENT)
Point of Care Technologies for Nutrition, Infection, and Cancer for Global Health (PORTENT)
批准号:
10714507
负责人:
David Carl Erickson
金额:
$24.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-13 至 2028-07-31
关键词:
Administrative CoordinationAdvisory CommitteesBiomedical TechnologyBusinessesClinicalCollaborationsConflict (Psychology)ConsensusDevelopmentDiagnosticDirect CostsDomestic PartnersEcologyEcuadorElementsEngineeringEnsureEvaluationFoundationsFundingFutureGoalsHumanHuman ResourcesIndiaIndustryInfectionInfrastructureInstitutionInstitutional Review BoardsInternationalKnowledgeLeadLettersMalignant NeoplasmsManufacturerMedical DeviceNatureNeeds AssessmentNew YorkNongovernmental OrganizationsPoint of Care TechnologyPositioning AttributeRecommendationRecording of previous eventsRequest for ApplicationsRequest for ProposalsResearchResearch PersonnelResourcesScientistSiteStructureTechnologyTrainingUgandaUnited States National Institutes of HealthUniversitiesValidationacademic programclinical practiceclinical research sitecollegecommercializationcost efficientexperienceglobal healthinnovationmeetingsmultidisciplinarynew technologynutritionoperationprogramsresponsesuccesssynergismtechnology development
中文摘要
全球健康的营养、感染和癌症护理点技术(征兆)
2.0管理核心
摘要
预兆中心的全球性需要一个独特的管理核心,具有丰富的
国际合作、研究管理、临床实践、需求评估和培训
和技术商业化。在生物医学技术方面有深厚的经验
与康奈尔大学合作开发、全球卫生、国际培训和中心管理
哥伦比亚大学和麦吉尔大学处于独特的地位,可以建立和管理这样的努力。
通过我们之前的能力建设努力,我们已经与所有先兆临床站点建立了关系
-包括IRBs-这将使中心的管理和执行更加高效和及时
项目。该中心的技术和临床方向将由外部咨询委员会指导--世卫组织
将帮助确定中心的总体方向,并支持新PoC项目的最终选择-以及
评估咨询委员会-将建立年度需求评估共识,以支持项目
引诱。中心的专业知识还将得到广泛的合作伙伴公司网络的支持,政府
和非政府组织,以及全球健康相关的学术项目。
与其他核心协调工作,行政核心的主要重点将是(1)有效
利用先兆的临床、技术和其他资源支持已资助的PoC项目,(2)
管理年度招标书征集新项目和评估现有项目,以及(3)建立和
管理咨询委员会,(4)确保三个国内合作伙伴网站和
四个主要临床站点,(5)维护外部伙伴关系网络并建立新的伙伴关系,以及(5)
管理中心的日常活动,包括财务、人力资源、行政支持和
冲突管理。
英文摘要
Point of Care Technologies for Nutrition, Infection and Cancer for Global Health (PORTENT)
2.0 Administration Core
Abstract
The global nature of the PORTENT center requires a unique administrative core with deep experience in
international collaboration, research administration, clinical practice, needs assessment and training
and technology commercialization. With deeply established experience in biomedical technology
development, global health, international training, and center management Cornell University in partnership with
Columbia University and McGill University are uniquely positioned to establish and manage such an effort.
Through our prior capacity building efforts, we have established relationships with all the PORTENT clinical sites
– including IRBs - which will enable much more efficient and timely administration and execution of center
projects. The technical and clinical direction of the center will be guided by an External Advisory Board – who
will help set the overall direction of the center and support the final selection of new PoC projects – and a Needs
Assessment Advisory Board – that will establish an annual needs assessment consensus to support project
solicitation. Center expertise will also be supported by an extensive network of partner companies, governmental
and non-governmental organizations, and global health related academic programs.
Working in concert with the other cores, the primary focus of the Administration Core will be to (1) Effectively
employ the PORTENT’s clinical, technical, and other resources in support of the funded PoC projects, (2)
Administer annual Requests for Proposals to solicit new and evaluate current projects, and (3) Establish and
manage the advisory committees, (4) Ensure overall coordination between the three domestic partner sites and
four primary clinical sites, (5) Maintain the network of external partnerships and establish new ones, and (5)
Manage the day-to-day activities of the center including financial, human resources, administrative support and
conflict management.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Point of Care Technologies for Nutrition, Infection, and Cancer for Global Health (PORTENT)
-
批准号:10714506
-
项目类别:
-
资助金额:$160.64万
-
财政年份:2023
-
负责人:David Carl Erickson
-
依托单位:
Artificial Intelligence and Precision Nutrition Training Program
-
批准号:10752485
-
项目类别:
-
资助金额:$32.44万
-
财政年份:2023
-
负责人:David Carl Erickson
-
依托单位:
Technology Core
-
批准号:10714508
-
项目类别:
-
资助金额:$68.04万
-
财政年份:2023
-
负责人:David Carl Erickson
-
依托单位:
Paper-COVID - Platform for High-throughput SARS-CoV-2 Screening and Contact Tracing
-
批准号:10196383
-
项目类别:
-
资助金额:$43.2万
-
财政年份:2021
-
负责人:David Carl Erickson
-
依托单位:
Development of a Point of Care Multiplexed Diagnostic Platform to Target Anemia and Micronutrient Deficiencies
-
批准号:9542788
-
项目类别:
-
资助金额:$11.39万
-
财政年份:2017
-
负责人:David Carl Erickson
-
依托单位:
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect
-
批准号:9334145
-
项目类别:
-
资助金额:$49.9万
-
财政年份:2016
-
负责人:David Carl Erickson
-
依托单位:
FeverPhone: Point of Care Diagnosis of Acute Febrile Illness using a Mobile Device
-
批准号:9008392
-
项目类别:
-
资助金额:$61.16万
-
财政年份:2016
-
负责人:David Carl Erickson
-
依托单位:
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect
-
批准号:9031275
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2016
-
负责人:David Carl Erickson
-
依托单位:
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect
-
批准号:10018466
-
项目类别:
-
资助金额:$90.68万
-
财政年份:2016
-
负责人:David Carl Erickson
-
依托单位:
FeverPhone: Point of Care Diagnosis of Acute Febrile Illness using a Mobile Device
-
批准号:9301546
-
项目类别:
-
资助金额:$60.03万
-
财政年份:2016
-
负责人:David Carl Erickson
-
依托单位:
A New Approach to Autonomous Point-of-care Tropical Disease Diagnostics Using Sol
-
批准号:8609568
-
项目类别:
-
资助金额:$17.45万
-
财政年份:2013
-
负责人:David Carl Erickson
-
依托单位:
A New Approach to Autonomous Point-of-care Tropical Disease Diagnostics Using Sol
-
批准号:8443640
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2013
-
负责人:David Carl Erickson
-
依托单位:
Single Molecule Optically Resonant NanoTweezers for the study of Intracellular Me
-
批准号:8601119
-
项目类别:
-
资助金额:$28.92万
-
财政年份:2013
-
负责人:David Carl Erickson
-
依托单位:
KS-Detect: A sample-in, answer-out solution to the Diagnosis of Kaposi's Sarcoma
-
批准号:8780631
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2013
-
负责人:David Carl Erickson
-
依托单位:
KS-Detect: A sample-in, answer-out solution to the Diagnosis of Kaposi's Sarcoma
-
批准号:8636238
-
项目类别:
-
资助金额:$23.28万
-
财政年份:2013
-
负责人:David Carl Erickson
-
依托单位:
Single Molecule Optically Resonant NanoTweezers for the study of Intracellular Me
-
批准号:8419345
-
项目类别:
-
资助金额:$27.65万
-
财政年份:2013
-
负责人:David Carl Erickson
-
依托单位:
Optically Resonant Nanotweezers
-
批准号:8069193
-
项目类别:
-
资助金额:$17.82万
-
财政年份:2010
-
负责人:David Carl Erickson
-
依托单位:
Optically Resonant Nanotweezers
-
批准号:7896973
-
项目类别:
-
资助金额:$22.47万
-
财政年份:2010
-
负责人:David Carl Erickson
-
依托单位:
Nanoscale Optofluidic Pathogen Detection
-
批准号:7640877
-
项目类别:
-
资助金额:$18.04万
-
财政年份:2007
-
负责人:David Carl Erickson
-
依托单位:
Nanoscale Optofluidic Pathogen Detection
-
批准号:7847743
-
项目类别:
-
资助金额:$0.78万
-
财政年份:2007
-
负责人:David Carl Erickson
-
依托单位:
海外基金